Financhill
Sell
32

OCSL Quote, Financials, Valuation and Earnings

Last price:
$16.04
Seasonality move :
-0.37%
Day range:
$16.02 - $16.14
52-week range:
$14.89 - $20.44
Dividend yield:
13.72%
P/E ratio:
23.93x
P/S ratio:
26.74x
P/B ratio:
0.91x
Volume:
509.4K
Avg. volume:
627K
1-year change:
-19.66%
Market cap:
$1.3B
Revenue:
$57.6M
EPS (TTM):
$0.67

Analysts' Opinion

  • Consensus Rating
    Oaktree Specialty Lending has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 5 Hold ratings, and 1 Sell rating.
  • Price Target Downside
    According to analysts' consensus price target of $15.92, Oaktree Specialty Lending has an estimated downside of -0.74% from its current price of $16.04.
  • Price Target Upside
    According to analysts, the highest upside price target is $18.00 representing -100% upside increase from its current price of $16.04.

Fair Value

  • According to the consensus of 7 analysts, Oaktree Specialty Lending has -0.74% downside to fair value with a price target of $15.92 per share.

OCSL vs. S&P 500

  • Over the past 5 trading days, Oaktree Specialty Lending has overperformed the S&P 500 by 3.99% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Oaktree Specialty Lending does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Oaktree Specialty Lending revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Oaktree Specialty Lending reported revenues of $3.1M.

Earnings Growth

  • Oaktree Specialty Lending earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Oaktree Specialty Lending reported earnings per share of $0.09.
Enterprise value:
2.8B
EV / Invested capital:
0.92x
Price / LTM sales:
26.74x
EV / EBIT:
15.32x
EV / Revenue:
56.94x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
17.19x
Price / Operating cash flow:
8.07x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.69%
Net Income Margin (TTM):
95.38%
Return On Equity:
3.66%
Return On Invested Capital:
1.75%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $11.7M $122.4M $48.9M $11.8M $3.1M
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.05 $1.53 $0.67 $0.14 $0.09
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $46.4M $95.4M $109.8M $213.8M $222.8M
Total Assets $1.8B $2.7B $2.8B $3.3B $3.1B
Current Liabilities $132M $77.3M $54.5M $99.2M $28M
Total Liabilities $829M $1.4B $1.6B $1.8B $1.6B
Total Equity $964.9M $1.3B $1.2B $1.5B $1.4B
Total Debt $694.8M $1.3B $1.5B $1.6B $1.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations -$110.7M $339.8M $161.9M $1.1M $144M
Cash From Investing -- -- -- -- --
Cash From Financing $83.9M -$228.3M -$167.4M -$14.6M -$95.3M
Free Cash Flow -$110.7M $339.8M $161.9M $1.1M $144M
OCSL
Sector
Market Cap
$1.3B
$661.6M
Price % of 52-Week High
78.47%
88.62%
Dividend Yield
13.72%
2%
Shareholder Yield
10.2%
3.91%
1-Year Price Total Return
-19.66%
11.07%
Beta (5-Year)
1.081
0.730
Dividend yield:
13.72%
Annualized payout:
$2.27
Payout ratio:
317.96%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $15.87
200-day SMA
Sell
Level $16.92
Bollinger Bands (100)
Buy
Level 15.45 - 16.33
Chaikin Money Flow
Buy
Level 25.9M
20-day SMA
Buy
Level $15.78
Relative Strength Index (RSI14)
Buy
Level 59.70
ADX Line
Buy
Level 14.99
Williams %R
Sell
Level -10.7143
50-day SMA
Buy
Level $15.58
MACD (12, 26)
Buy
Level 0.11
25-day Aroon Oscillator
Buy
Level 48
On Balance Volume
Sell
Level -46M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.3775)
Sell
CA Score (Annual)
Level (-0.3433)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.8144)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

Stock Forecast FAQ

In the current month, OCSL has received 1 Buy ratings 5 Hold ratings, and 1 Sell ratings. The OCSL average analyst price target in the past 3 months is $15.92.

  • Where Will Oaktree Specialty Lending Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Oaktree Specialty Lending share price will drop to $15.92 per share over the next 12 months.

  • What Do Analysts Say About Oaktree Specialty Lending?

    Analysts are divided on their view about Oaktree Specialty Lending share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oaktree Specialty Lending is a Sell and believe this share price will rise from its current level to $15.00.

  • What Is Oaktree Specialty Lending's Price Target?

    The price target for Oaktree Specialty Lending over the next 1-year time period is forecast to be $15.92 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is OCSL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Oaktree Specialty Lending is a Hold. 5 of 7 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of OCSL?

    You can purchase shares of Oaktree Specialty Lending via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oaktree Specialty Lending shares.

  • What Is The Oaktree Specialty Lending Share Price Today?

    Oaktree Specialty Lending was last trading at $16.04 per share. This represents the most recent stock quote for Oaktree Specialty Lending. Yesterday, Oaktree Specialty Lending closed at $16.04 per share.

  • How To Buy Oaktree Specialty Lending Stock Online?

    In order to purchase Oaktree Specialty Lending stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Walmart Stock Fall?
Why Did Walmart Stock Fall?

Walmart (NYSE:WMT) tumbled in spite of strong Q4 results that…

Is Cadence Stock a Buy, Sell or Hold?
Is Cadence Stock a Buy, Sell or Hold?

Cadence Design Systems (NASDAQ:CDNS) has seen its stock move sharply…

Is PFE the Best Dividend Play in Its Industry?
Is PFE the Best Dividend Play in Its Industry?

By their inherent nature, established pharma companies face a demand…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 22

Globant SA [GLOB] is down 27.81% over the past day.

Sell
42
CELH alert for Feb 22

Celsius Holdings [CELH] is up 27.77% over the past day.

Buy
60
HIMS alert for Feb 22

Hims & Hers Health [HIMS] is down 25.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock